Discovery and Translational Sciences|Pneumonia & Pandemic Preparedness

Grant number: INV-031624

Grant search

Key facts

  • Disease

    COVID-19, Severe Acute Respiratory Syndrome (SARS)
  • Start & end year

    2021
    2024
  • Known Financial Commitments (USD)

    $2,900,000
  • Funder

    Gates Foundation
  • Principal Investigator

    N/A

  • Research Location

    United States of America
  • Lead Research Institution

    University of Texas at Austin
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

to engineer potent S2 pan B-coronavirus immunogens and mABs with broad multi-functional activity

Publicationslinked via Europe PMC

Distinct pathways for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses.

Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens.

Concurrent Administration of COVID-19 and Influenza Vaccines Enhances Spike-Specific Antibody Responses.

Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge.

Understanding Fc function for rational vaccine design against pathogens.